Funding for this research was provided by:
Takeda Pharmaceuticals Ltd
Text and Data Mining valid from 2018-09-07
First Online: 7 September 2018
Compliance with Ethical Standards
: This study was funded by Takeda Pharmaceutical Company Ltd.
: Yukio Shimasaki, TK, Takuya Saiki, Kumi Matsuno, Yuhei Sano, Shingo Kuroda, and Emiko Koumura report current or past employment with Takeda Pharmaceutical Company Ltd. EK reports stock/stock options with Takeda. Yukio Shimasaki, Masashi Sakaki, Minoru Itou, Tokurou Kobayashi, Masako Aso, Tomoya Kagawa, Takuya Saiki, Kumi Matsuno, Yuhei Sano, Kohei Shimizu, Shingo Kuroda, and Emiko Koumura report that medical writing assistance was provided by BlueMomentum, an Ashfield company, and supported by Takeda.
: All procedures performed in studies involving human participants were in accordance with Japanese regulatory requirements and the ethical standards of the World Medical Association’s Declaration of Helsinki. The study protocol was approved by the institutional review board of each study site: Kurume Clinical Pharmacology Clinic (Institutional Review Board of Kurume Clinical Pharmacology Clinic), Moriya Keiyu Hospital (Review Board of Human Rights and Ethics for Clinical Studies Institutional Review Board), Kitasato University Hospital (Kitasato University Hospital Institutional Review Board), and Showa University Hospital (Institutional Review Board of Showa University Hospital).
: Informed consent was obtained from all individual participants included in the study.